BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16286163)

  • 1. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
    Vicari RM; Chaitman B; Keefe D; Smith WB; Chrysant SG; Tonkon MJ; Bittar N; Weiss RJ; Morales-Ballejo H; Thadani U;
    J Am Coll Cardiol; 2005 Nov; 46(10):1803-11. PubMed ID: 16286163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
    Shimokawa H; Hiramori K; Iinuma H; Hosoda S; Kishida H; Osada H; Katagiri T; Yamauchi K; Yui Y; Minamino T; Nakashima M; Kato K
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):751-61. PubMed ID: 12409984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Hirai S; Seto M; Satoh S; Ohtomo E;
    J Neurol Sci; 2005 Nov; 238(1-2):31-9. PubMed ID: 16005902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
    Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
    Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
    J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.
    Otsuka T; Ibuki C; Suzuki T; Ishii K; Yoshida H; Kodani E; Kusama Y; Atarashi H; Kishida H; Takano T; Mizuno K
    Coron Artery Dis; 2008 Mar; 19(2):105-10. PubMed ID: 18300747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
    Di Pasquale G; Lusa AM; Manini GL; Dominici P; Coluccini M; Bassein L; Pinelli G
    G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of depot diltiazem in stable effort angina: a double-blind study compared with placebo].
    Baldi N; Guiducci U; Piccitto R
    G Ital Cardiol; 1996 May; 26(5):527-32. PubMed ID: 8767776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.